Le Lézard3d
Dx&Vx Presents a New Paradigm for Next-Generation Infectious Disease Response with the Development of a Universal Vaccine
Since the COVID-19 pandemic, mRNA vaccines have been recognized as the most important platform for infectious disease prevention and continue to be utilized across various fields.
scienceopen.com19d
Development of chimeric MrNV virus-like particles capable of binding to SARS-CoV-2-susceptible cells and reducing infection by pseudovirus variants
Summary Background A recent cluster of pneumonia cases in Wuhan, China, was caused by a novel betacoronavirus, the 2019 novel coronavirus (2019-nCoV). We report the epidemiological, clinical, ...
Medscape22d
Currently Approved Prophylactic HPV Vaccines
HPV: Human papillomavirus; VLP: Virus-like particle. Data from [16,73]. ‡ Those in the ATP-E but HPV type assignment algorithm were used to resolve causation when multiple HPV types were present.
University of Leeds28d
Speeding up new vaccine development
Dr Raafat Fahim, CEPI Acting Executive Director of Manufacturing and Supply Chain, said: “Virus-like particle-based vaccines are well established already, but—until now—the development process has ...
Frontiers4y
Design Concepts of Virus-Like Particle-Based HIV-1 Vaccines
Owing to immunogenic, structural, and functional diversity, virus-like particles (VLPs) could act as efficient vaccine carriers to display HIV-1 immunogens and provide a variety of HIV-1 vaccine ...